Financial Performance Overview
Chembond Material Technologies Limited reported consolidated revenue growth of 25% to ₹250.07 crore in FY26, though profitability declined significantly with PBT down 20% to ₹15.51 crore and PAT declining 27% to ₹12.89 crore. The company faced margin pressure from raw material cost inflation despite maintaining strong financial ratios with current ratio of 2.37 and minimal debt (Debt/Equity: 0.02).
Segment Performance & Operations
The company operates in two reportable segments: Specialty Chemicals (83.15% of revenue, ₹207.93 crore) and Animal Health (16.85%, ₹42.15 crore). Key developments include substantial R&D investment of ₹3.59 crore, establishment of a new ₹5 crore R&D center at Alandi, and expansion into electronic adhesives and battery pack adhesives for EV markets. Capital expenditure of ₹13.43 crore was completed in property, plant and equipment.
Corporate Actions & Governance
The Board recommended a final dividend of ₹2.00 per share (40%) for FY26, subject to shareholder approval at the 51st AGM scheduled for July 17, 2026, to be held virtually. The company implemented the Chembond ESOP 2025 Scheme, granting 34,438 stock options to eligible employees. Corporate governance structure includes a 7-member board with all required committees functional.
Financial Position & Contingencies
The company maintained investments valued at ₹69.58 crore primarily in mutual funds and equity shares. Significant contingent liabilities include GST demands of ₹178.48 lakhs, service tax dues of ₹259.42 lakhs, and ongoing legal disputes with Davendra Feeds India Private Limited and Rajkumar Mor of Mor Hatcheries regarding product quality issues. The company had working capital facilities of ₹107.25 crore with utilization of ₹415.70 lakhs in cash credit facilities.
Outlook & Challenges
Opportunities include growth in Indian automotive industry, expansion projects in steel sector, and rising protein consumption driving animal health business. Threats include intense competition from global MNCs, price-led margin pressure, geopolitical events affecting supply chain, and environmental hazards in chemical manufacturing. The company maintained CRISIL BBB+/Watch Negative rating for long-term borrowings.